Challenge: Biopharma companies are faced with unprecedented obstacles to discover new drug targets and to develop scalable solutions to bring those new drugs to market. In fact, about nine out of 10 drug candidates fail to reach the market. With costs and timelines increasing, many companies are seeking improved clarity across the R&D process. Metabolon’s bioprocessing insights enable our biopharma partners to understand the factors that influence bioprocess such as genetics, operational environments, and nutritional requirements.
Approach: Leveraging our Precision Metabolomics™ platform, Metabolon can build pharmaceutical R&D program confidence and reduce attrition by helping to select high-quality drug development targets, molecules and translatable biomarkers across all major therapeutic areas.
Our platform unlocks the power of the metabolome, offering critical insight into disease states, the microbiome, compounds, and drug responses to advance pharmaceutical R&D. It can be used to help select the correct patient populations, to pursue the right targets, and to design more precise preclinical models for faster, more cost-efficient clinical development.
With thousands of metabolomics studies for leading biopharma companies, we offer metabolomics services to meet our clients’ needs at every stage of R&D, from discovery metabolomics for preclinical studies , to targeted metabolomics-focused panels and custom-built clinical biomarker assays for clinical drug development.
- Global Metabolomics – This Global Metabolomics Service provides a statistical analysis of resulting data, deep biochemical interpretation of selected, statistically significant metabolites and an outline of analytical methods used.
- Custom Targeted Assay Development – Our targeted assay program is tailored to the needs of your program to the specifications of our innovative and standardized sample prep and handling process. Various sample analysis report options are available.
- Program Development Dossier – This valuable tool provides Metabolon’s superior methodology and access to our vast metabolite library to capture a more complete story about your molecule at every stage.